Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 19/10/2018
SIETES contiene 92571 citas

 
 
 1 a 17 de 17 
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Pottegård A, Pedersen SA, Alba S, Schmidt J, Hölmich LR, Friis S, Gaist D. Association of hydrochlorothiazide use and risk of malignant melanoma. JAMA Intern Med 2018;178:1120-2. [Ref.ID 102645]
2. Cita con resumen
de Koning Svendsen T, Hansen PN, García Rodríguez LA, Andersen L, Hallas J, Sindrup SH, Gaist D. Statins and polyneuropathy revisited: case-control study in Denmark, 1999–2013. Br J Clin Pharmacol 2017;83:2087-95. [Ref.ID 102032]
3.Enlace a cita original Cita con resumen
Andersen L, Friis S, Hallas J, Ravn P, Kristensen BW, Gaist D. Hormonal contraceptive use and risk of glioma among younger women a nationwide case-control study. Br J Clin Pharmacol 2015;79:677-84. [Ref.ID 98752]
4. Cita con resumen
Gaist D, Wallander M-A, González-Pérez A, García-Rodríguez LA. Incidence of hemorrhagic stroke in the general population: validation of data from The Health Improvement Network. Pharmacoepidemiol Drug Saf 2013;22:176-82. [Ref.ID 94868]
5.
Gaist D, García Rodríguez LA, Huerta C, Hallas J, Sindrup SH. Are users of lipid-lowering drugs at increased risk of peripheral neuropathy?. Eur J Clin Pharmacol 2001;56:931-3. [Ref.ID 55938]
6.Tiene citas relacionadas
Gaist D, Christensen K, Vaeth M, Tsiropoulos I, Olsen J, Sorensen HT. Incidence of hospital admission does not equal incidence of disease. Authors' reply. BMJ 2000;320:1277. [Ref.ID 50771]
7. Cita con resumen
Gaist D, Vaeth M, Tsiropoulos I, Christensen K, Corder E, Olsen J, Sorensen HT. Risk of subarachnoid haemorrhage in first degree relatives of patients with subarachnoid haemorrhage: follow up study based on national registries in Denmark. BMJ 2000;320:141-5. [Ref.ID 48787]
8.
Jeppesen U, Gaist D, Smith T, Sindrup SH. Statins and peripheral neuropathy. Eur J Clin Pharmacol 1999;54:835-8. [Ref.ID 42686]
9.
Gaist D, Tsiropoulos I, Sindrugp SH, Hallas J, Rasmussen B K, Kragstrup J, Gram LF. Inappropriate use of sumatriptan: population based register and interview study. BMJ 1998;316:1352-3. [Ref.ID 39543]
10.
Hansen NC, Gaist D, Hallas J, Castellsagué J, Pérez Gutthann S, Andersen M, Gram LF. The use of inhaled long-acting ß2-agonists in a Danish county, 1992-1996. Pharmacoepidemiol Drug Saf 1997;6:18. [Ref.ID 34044]
11.
Gaist D, Andersen M, Aarup A-L, Hallas J, Gram LF. Use and overuse of sumatriptan: an analysis of nationwide Danish prescription register data. Pharmacoepidemiol Drug Saf 1997;6:17. [Ref.ID 34043]
12.
Gaist D, Andersen M, Aarup A-L, Hallas J, Gram LF. Use of sumatriptan in Denmark in 1994-5: an epidemiological analysis of nationwide prescription data. Br J Clin Pharmacol 1997;43:429-33. [Ref.ID 31996]
13.
Gaist D, Hallas J, Sindrup SH, Gram LF. Is overuse os sumatriptan a problem?. A population - based study. Eur J Clin Pharmacol 1996;50:161-5. [Ref.ID 26991]
14.
Gaist D, Andersen M, Schou JS. Spontaneous reports of drug - induced erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in Denmark 1968-1991. Pharmacoepidemiol Drug Saf 1996;5:79-86. [Ref.ID 26739]
15. Cita con resumen
Gaist D, Hallas J, Hansen NCG, Gram LF. Are young adults with asthma treated sufficiently with inhaled steroids? A population-based study of prescription data from 1991 and 1994. Br J Clin Pharmacol 1996;41:285-9. [Ref.ID 26332]
16. Cita con resumen
Bergholm U, Langman M, Rawlins M, Gaist D, Andersen M, Edwards IR, Wiholm BE. Drug-induced acute pancreatitis. Pharmacoepidemiol Drug Saf 1995;4:329-34. [Ref.ID 25667]
17. Cita con resumen
Gaist D, Sindrup S, Hallas J, Gram LF. Misuse of sumatriptan. Lancet 1994;344:1090. [Ref.ID 22922]
Seleccionar todas
 
 1 a 17 de 17